Skip to main content
Top
Published in: Pathology & Oncology Research 4/2015

Open Access 01-09-2015 | Research

Single Nucleotide Polymorphisms (SNPs) of RAD51-G172T and XRCC2-41657C/T Homologous Recombination Repair Genes and the Risk of Triple- Negative Breast Cancer in Polish Women

Authors: Magdalena M. Michalska, Dariusz Samulak, Hanna Romanowicz, Beata Smolarz

Published in: Pathology & Oncology Research | Issue 4/2015

Login to get access

Abstract

Double strand DNA breaks are the most dangerous DNA damage which, if non-repaired or misrepaired, may result in genomic instability, cancer transformation or cell death. RAD51 and XRCC2 encode proteins that are important for the repair of double-strand DNA breaks by homologous recombination. Therefore, genetic variability in these genes may contribute to the occurrence and progression of triple-negative breast cancer. The polymorphisms of the XRCC2 gene -41657C/T (rs718282) and of the RAD51 gene, −172G/T (rs1801321), were investigated by PCR-RFLP in 70 patients with triple-negative breast cancer and 70 age- and sex matched non-cancer controls. The obtained results demonstrated a significant positive association between the RAD51 T/T genotype and TNBC, with an adjusted odds ratio (OR) of 4.94 (p = 0.001). The homozygous T/T genotype was found in 60 % of TNBC cases and in 14 % of the used controls. Variant 172 T allele of RAD51 increased cancer risk (OR = 2.81 (1.72–4.58), p < .0001). No significant associations were observed between -41657C/T genotype of XRCC2 and the incidence of TNBC. There were no significant differences between the distribution of XRCC2 -41657C/T genotypes in the subgroups assigned to histological grades. The obtained results indicate that the polymorphism of RAD51, but not of XRCC2 gene, may be positively associated with the incidence of triple-negative breast carcinoma in the population of Polish women.
Literature
1.
go back to reference Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the socalled triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer 109:1721–1728CrossRefPubMed Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the socalled triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer 109:1721–1728CrossRefPubMed
3.
go back to reference Cleator S, Heller W, Coombes RC (2007) Triple-negative breast cancer: therapeutic options. Lancet Oncol 8:235–244CrossRefPubMed Cleator S, Heller W, Coombes RC (2007) Triple-negative breast cancer: therapeutic options. Lancet Oncol 8:235–244CrossRefPubMed
4.
go back to reference Dawson SJ, Provenzano E, Caldas C (2009) Triple negative breast cancers: clinical and prognostic implications. Eur J Cancer 45:27–40CrossRefPubMed Dawson SJ, Provenzano E, Caldas C (2009) Triple negative breast cancers: clinical and prognostic implications. Eur J Cancer 45:27–40CrossRefPubMed
5.
go back to reference de Ruijter TC, Veeck J, de Hoon JP, van Engeland M, Tjan-Heijnen VC (2011) Characteristics of triple-negative breast cancer. J Cancer Res Clin Oncol 137:183–192PubMedCentralCrossRefPubMed de Ruijter TC, Veeck J, de Hoon JP, van Engeland M, Tjan-Heijnen VC (2011) Characteristics of triple-negative breast cancer. J Cancer Res Clin Oncol 137:183–192PubMedCentralCrossRefPubMed
6.
7.
go back to reference Helleday T (2003) Pathways for mitotic homologous recombination in mammalian cells. Mutat Res 532:103–115CrossRefPubMed Helleday T (2003) Pathways for mitotic homologous recombination in mammalian cells. Mutat Res 532:103–115CrossRefPubMed
8.
9.
go back to reference Hasselbach L, Haase S, Fischer D, Kolberg HC, Stürzbecher HW (2005) Characterisation of the promoter region of the human DNA-repair gene RAD51. Eur J Gynaecol Oncol 26:589–598PubMed Hasselbach L, Haase S, Fischer D, Kolberg HC, Stürzbecher HW (2005) Characterisation of the promoter region of the human DNA-repair gene RAD51. Eur J Gynaecol Oncol 26:589–598PubMed
10.
go back to reference Antoniou AC, Sinilnikova OM, Simard J et al (2007) RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 81:1186–1200PubMedCentralCrossRefPubMed Antoniou AC, Sinilnikova OM, Simard J et al (2007) RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 81:1186–1200PubMedCentralCrossRefPubMed
11.
go back to reference Krivokuca AM, Malisic EJ, Dobricic JD, Brotto KV, Cavic MR, Jankovic RN, Tomasevic ZI, Brankovic-Magic MV (2014) RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women. Fam Cancer.13: 173–80 Krivokuca AM, Malisic EJ, Dobricic JD, Brotto KV, Cavic MR, Jankovic RN, Tomasevic ZI, Brankovic-Magic MV (2014) RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women. Fam Cancer.13: 173–80
12.
go back to reference Wang W, Li JL, He XF, Li AP, Cai YL, Xu N, Sun SM, Wu BY (2013) Association between the RAD51 135 G > C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls. PLoS ONE 8:e75153PubMedCentralCrossRefPubMed Wang W, Li JL, He XF, Li AP, Cai YL, Xu N, Sun SM, Wu BY (2013) Association between the RAD51 135 G > C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls. PLoS ONE 8:e75153PubMedCentralCrossRefPubMed
13.
go back to reference Romanowicz-Makowska H, Smolarz B, Zadrozny M, Westfa B, Baszczyński J, Kokołaszwili G, Burzyfiski M, Połać I, Sporny S (2012) The association between polymorphisms of the RAD51-G135C, XRCC2-Arg188His and XRCC3-Thr241Met genes and clinico-pathologic features in breast cancer in Poland. Eur J Gynaecol Oncol 33:145–150PubMed Romanowicz-Makowska H, Smolarz B, Zadrozny M, Westfa B, Baszczyński J, Kokołaszwili G, Burzyfiski M, Połać I, Sporny S (2012) The association between polymorphisms of the RAD51-G135C, XRCC2-Arg188His and XRCC3-Thr241Met genes and clinico-pathologic features in breast cancer in Poland. Eur J Gynaecol Oncol 33:145–150PubMed
14.
go back to reference Romanowicz-Makowska H, Smolarz B, Zadrozny M, Westfal B, Baszczynski J, Polac I, Sporny S (2011) Single nucleotide polymorphisms in the homologous recombination repair genes and breast cancer risk in Polish women. Tohoku J Exp Med 224:201–208CrossRefPubMed Romanowicz-Makowska H, Smolarz B, Zadrozny M, Westfal B, Baszczynski J, Polac I, Sporny S (2011) Single nucleotide polymorphisms in the homologous recombination repair genes and breast cancer risk in Polish women. Tohoku J Exp Med 224:201–208CrossRefPubMed
15.
go back to reference Lee KM, Choi JY, Kang C, Kang CP, Park SK, Cho H, Cho DY, Yoo KY, Noh DY, Ahn SH, Park CG, Wei Q, Kang D (2005) Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clin Cancer Res 11:4620–4626CrossRefPubMed Lee KM, Choi JY, Kang C, Kang CP, Park SK, Cho H, Cho DY, Yoo KY, Noh DY, Ahn SH, Park CG, Wei Q, Kang D (2005) Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clin Cancer Res 11:4620–4626CrossRefPubMed
16.
go back to reference Shin A, Lee KM, Ahn B, Park CG, Noh SK, Park DY, Ahn SH, Yoo KY, Kang D (2008) Genotype-phenotype relationship between DNA repair gene genetic polymorphisms and DNA repair capacity. Asian Pac J Cancer Prev 9:501–505PubMed Shin A, Lee KM, Ahn B, Park CG, Noh SK, Park DY, Ahn SH, Yoo KY, Kang D (2008) Genotype-phenotype relationship between DNA repair gene genetic polymorphisms and DNA repair capacity. Asian Pac J Cancer Prev 9:501–505PubMed
17.
go back to reference Kuschel B, Auranen A, McBride S (2002) Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11:1399–40722CrossRefPubMed Kuschel B, Auranen A, McBride S (2002) Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11:1399–40722CrossRefPubMed
18.
go back to reference Thacker J, Zdzienicka MZ (2004) The XRCC genes: expanding roles in DNA double-strand break repair. DNA Repair (Amst) 3:1081–1090CrossRef Thacker J, Zdzienicka MZ (2004) The XRCC genes: expanding roles in DNA double-strand break repair. DNA Repair (Amst) 3:1081–1090CrossRef
19.
go back to reference Silva SN, Tomar M, Paulo C, Gomes BC, Azevedo AP, Teixeira V, Pina JE, Rueff J, Gaspar JF (2010) Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51. Cancer Epidemiol 34:85–92CrossRefPubMed Silva SN, Tomar M, Paulo C, Gomes BC, Azevedo AP, Teixeira V, Pina JE, Rueff J, Gaspar JF (2010) Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51. Cancer Epidemiol 34:85–92CrossRefPubMed
20.
21.
go back to reference Sliwinski T, Krupa R, Majsterek I et al (2005) Polymorphisms of the BRCA2 and RAD51 genes in breast cancer. Breast Cancer Res Treat 94:105–109CrossRefPubMed Sliwinski T, Krupa R, Majsterek I et al (2005) Polymorphisms of the BRCA2 and RAD51 genes in breast cancer. Breast Cancer Res Treat 94:105–109CrossRefPubMed
22.
go back to reference Wang N, Xiu-juan D, Rong-miao Z, Wei G, Xiao-juan Z, Yan L (2009) An investigation on the polymorphisms of two DNA repair genes and susceptibility to ESCC and GCA of high-incidence region in northern China. Mol Biol Rep 36:357–364CrossRefPubMed Wang N, Xiu-juan D, Rong-miao Z, Wei G, Xiao-juan Z, Yan L (2009) An investigation on the polymorphisms of two DNA repair genes and susceptibility to ESCC and GCA of high-incidence region in northern China. Mol Biol Rep 36:357–364CrossRefPubMed
23.
go back to reference Lu J, Wang LE, Xiong P, Sturgis EM, Spitz MR, Wei Q (2007) 172G > T variant in the 5′ untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis 28:988–994CrossRefPubMed Lu J, Wang LE, Xiong P, Sturgis EM, Spitz MR, Wei Q (2007) 172G > T variant in the 5′ untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis 28:988–994CrossRefPubMed
24.
go back to reference Davidson JM, Gorringe KL, Chin SF, Orsetti B, Besret C, Courtay-Cahen C, Roberts I, Theillet C, Caldas C, Edwards PA (2000) Molecular cytogenetic analysis of breast cancer cell lines. Br J Cancer 83:1309–1317PubMedCentralCrossRefPubMed Davidson JM, Gorringe KL, Chin SF, Orsetti B, Besret C, Courtay-Cahen C, Roberts I, Theillet C, Caldas C, Edwards PA (2000) Molecular cytogenetic analysis of breast cancer cell lines. Br J Cancer 83:1309–1317PubMedCentralCrossRefPubMed
25.
go back to reference Loveday RL, Greenman J, Simcox DL, Speirs V, Drew PJ, Monson JR, Kerin MJ (2000) Genetic changes in breast cancer detected by comparative genomic hybridisation. Int J Cancer 86:494–500CrossRefPubMed Loveday RL, Greenman J, Simcox DL, Speirs V, Drew PJ, Monson JR, Kerin MJ (2000) Genetic changes in breast cancer detected by comparative genomic hybridisation. Int J Cancer 86:494–500CrossRefPubMed
26.
go back to reference Zhao M, Chen P, Dong Y, Zhu X, Zhang X (2014) Relationship between Rad51 G135C and G172T variants and the susceptibility to cancer: a meta-analysis involving 54 case–control studies. PLoS ONE 9:e87259PubMedCentralCrossRefPubMed Zhao M, Chen P, Dong Y, Zhu X, Zhang X (2014) Relationship between Rad51 G135C and G172T variants and the susceptibility to cancer: a meta-analysis involving 54 case–control studies. PLoS ONE 9:e87259PubMedCentralCrossRefPubMed
27.
go back to reference Smolarz B, Zadrożny M, Duda-Szymańska J, Makowska M, Samulak D, Michalska MM, Mojs E, Bryś M, Forma E, Romanowicz-Makowska H (2013) RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women. Pol J Pathol 64:39–43CrossRefPubMed Smolarz B, Zadrożny M, Duda-Szymańska J, Makowska M, Samulak D, Michalska MM, Mojs E, Bryś M, Forma E, Romanowicz-Makowska H (2013) RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women. Pol J Pathol 64:39–43CrossRefPubMed
28.
go back to reference Hosseini M, Houshmand M, Ebrahimi A (2013) RAD51 polymorphisms and breast cancer risk. Mol Biol Rep 40:665–668CrossRefPubMed Hosseini M, Houshmand M, Ebrahimi A (2013) RAD51 polymorphisms and breast cancer risk. Mol Biol Rep 40:665–668CrossRefPubMed
29.
go back to reference Romanowicz-Makowska H, Smolarz B, Gajęcka M, Kiwerska K, Rydzanicz M, Kaczmarczyk D, Olszewski J, Szyfter K, Błasiak J, Morawiec-Sztandera A (2012) Polymorphism of the DNA repair genes RAD51 and XRCC2 in smoking- and drinking-related laryngeal cancer in a Polish population. Arch Med Sci 8:1065–1075PubMedCentralCrossRefPubMed Romanowicz-Makowska H, Smolarz B, Gajęcka M, Kiwerska K, Rydzanicz M, Kaczmarczyk D, Olszewski J, Szyfter K, Błasiak J, Morawiec-Sztandera A (2012) Polymorphism of the DNA repair genes RAD51 and XRCC2 in smoking- and drinking-related laryngeal cancer in a Polish population. Arch Med Sci 8:1065–1075PubMedCentralCrossRefPubMed
30.
go back to reference Improta G, Sgambato A, Bianchino G, Zupa A, Grieco V, La Torre G, Traficante A, Cittadini A (2008) Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case–control study in a Southern Italian population. Anticancer Res 28:2941–2946PubMed Improta G, Sgambato A, Bianchino G, Zupa A, Grieco V, La Torre G, Traficante A, Cittadini A (2008) Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case–control study in a Southern Italian population. Anticancer Res 28:2941–2946PubMed
31.
go back to reference Lu PH, Li C, Zhou HY, Wang T, Chu CQ, Shen W, Tao GQ (2011) Same data sources, different pooled analysis result: the ongoing uncertainty in the subgroup analysis of RAD51 135G/C polymorphism and breast cancer risk. Breast Cancer Res Treat 125:299–300CrossRefPubMed Lu PH, Li C, Zhou HY, Wang T, Chu CQ, Shen W, Tao GQ (2011) Same data sources, different pooled analysis result: the ongoing uncertainty in the subgroup analysis of RAD51 135G/C polymorphism and breast cancer risk. Breast Cancer Res Treat 125:299–300CrossRefPubMed
32.
go back to reference Sliwinski T, Walczak A, Przybylowska K et al (2010) Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a polish population. Exp Mol Pathol 89:358–366CrossRefPubMed Sliwinski T, Walczak A, Przybylowska K et al (2010) Polymorphisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a polish population. Exp Mol Pathol 89:358–366CrossRefPubMed
33.
go back to reference Li F, Li C, Jiang Z, Ma N, Gao X (2011) XRCC3 T241M polymorphism and bladder cancer risk: a meta-analysis. Urology 77:511–515PubMed Li F, Li C, Jiang Z, Ma N, Gao X (2011) XRCC3 T241M polymorphism and bladder cancer risk: a meta-analysis. Urology 77:511–515PubMed
34.
go back to reference Smolarz B, Samulak D, Michalska M, Góralczyk B, Szyłło K, Lewy J, Sporny S, Kokołaszwili G, Burzyński M, Romanowicz-Makowska H (2011) 135G > C and 172G > T polymorphism in the 5′ untranslated region of RAD51 and sporadic endometrial cancer risk in Polish women. Pol J Pathol 62:157–162PubMed Smolarz B, Samulak D, Michalska M, Góralczyk B, Szyłło K, Lewy J, Sporny S, Kokołaszwili G, Burzyński M, Romanowicz-Makowska H (2011) 135G > C and 172G > T polymorphism in the 5′ untranslated region of RAD51 and sporadic endometrial cancer risk in Polish women. Pol J Pathol 62:157–162PubMed
Metadata
Title
Single Nucleotide Polymorphisms (SNPs) of RAD51-G172T and XRCC2-41657C/T Homologous Recombination Repair Genes and the Risk of Triple- Negative Breast Cancer in Polish Women
Authors
Magdalena M. Michalska
Dariusz Samulak
Hanna Romanowicz
Beata Smolarz
Publication date
01-09-2015
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 4/2015
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-015-9922-y

Other articles of this Issue 4/2015

Pathology & Oncology Research 4/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine